Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-18

Clinical Trial Update: Vogelxo(R) ABPM Study in Hypogandal Men [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of Vogelxo ABPM in male hypogonadism has completed; the snippet notes the status as COMPLETED but does not provide results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VOGELXO (TESTOSTERONE)

Snippet

Sponsor: Upsher-Smith Laboratories | Conditions: Hypogonadism, Male | Phase 4 | Status: COMPLETED